Glenmark Life SciencesGLS 
$12.47-0.24%24h
-0.24%24h
Global rank6159
Market cap$1.53B
Change 7d6.67%
YTD Performance58.63%
SP500 benchmarkOutperform
P/E0.33
P/S6.25
Revenue$244.33M
Earnings$55.71M
Dividend yield-
Main Sector
Healthcare
Category
Glenmark Life Sciences (GLS) Cash on Hand
GLS Cash on Hand in 2022: $39.11M
According to Glenmark Life Sciences latest financial reports the cash on hand of GLS is $39.11M, an decrease of -36.63% to 2022. At the end of 2022 company had $61.72M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
GLS Cash on Hand History from 2019 to 2023
-
Value:-
GLS Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $39.11M | -36.63% |
| 2022 | $61.72M | 270.14% |
| 2021 | $16.68M | 354.24% |
| 2020 | $3.67M | 292.05% |
| 2019 | $936.36K | - |
View the Top Cash on Hand Companies 
